BACKGROUND: Neuroblastoma survivors may be at elevated risk for psychological impairments because of their young age at diagnosis and neurotoxic treatment, but this is not well described. METHODS: A total of 859 5-year survivors of neuroblastoma younger than 18 years (diagnosed in 1970-1999), who had a median age at diagnosis of 0.8 years (range: 0.0-7.3 years) and a median followup of 13.3 years (range: 8.0-17.9 years), were compared with 872 siblings of childhood cancer survivors who were younger than 18 years with the parent-reported Behavior Problem Index (BPI) for psychological functioning. Age-and sex-adjusted multivariate logbinomial models were used to identify factors associated with impairment in BPI domains (scores worse than the sibling 10th percentile). The impact of psychological impairment on educational outcomes was examined among survivors. RESULTS: Compared with siblings, neuroblastoma survivors had an increased prevalence of impairment in the domains of anxiety/depression (19% vs 14%; P 5.003), headstrong behavior (19% vs 13%; P <.001), attention deficits (21% vs 13%; P <.001), peer conflict/social withdrawal (26% vs 17%; P <.001), and antisocial behavior (16% vs 12%; P 5.01). Common treatment exposures (vincristine, cisplatin, and retinoic acid) were not associated with impairment. Having 2 or more chronic health conditions predicted impairment in 4 domains (P <.001). Specifically, pulmonary disease predicted impairment in all 5 domains (P .004). Endocrine disease (P .004) and peripheral neuropathy (P .02) each predicted impairment in 3 domains. Psychological impairment was associated with special education service usage and educational attainment less than college. CONCLUSIONS: Neuroblastoma survivors are at elevated risk for psychological impairment, which is associated with special education service usage and lower adult educational attainment. Those with chronic health conditions may represent a high-risk group for targeted screening and intervention. Cancer
INTRODUCTION
Since 1975, treatment advances for neuroblastoma have resulted in an increase in 5-year overall survival from 46% to 71%. 1 During this time, the standard of care for these patients has evolved, with lower risk patients receiving progressively de-escalated therapy and higher risk patients receiving increasingly more intensive treatments. 2, 3 Subsets of neuroblastoma survivors may be vulnerable to long-term health impairments because of their young age at diagnosis and the specific therapies that they receive. However, late psychological effects of treatment are understudied in this population. [4] [5] [6] [7] In the United States, children with neuroblastoma are diagnosed at a median age of 17.3 months. 8, 9 This young age may place them at increased risk for psychological impairment because of contributions from both the early biologic insult to the developing central nervous system 10 and the disruption of normal psychosocial development by intensive cancer treatment. 11, 12 There are known associations between cognitive functioning and neurologic vulnerability at younger ages after the receipt of cranial radiation and/or chemotherapy alone in survivors of other pediatric cancers. 10, 13, 14 Neuroblastoma chemotherapy regimens typically contain agents that are directly neurotoxic and/or can result in cardiovascular insufficiency, which is hypothesized to cause psychological impairment. 2, 3, 15 Long-term psychological impairment in neuroblastoma survivors is not well characterized because, until recently, many died of their disease. The Childhood Cancer Survivor Study (CCSS) can address this knowledge gap because detailed treatment exposures over the last 3 decades of evolving therapeutic protocols have been abstracted and a uniform ascertainment of psychological outcomes with standardized instruments has been collected. The specific aims of this study were to 1) characterize the overall patterns and severity of psychological difficulties in long-term survivors of neuroblastoma, 2) identify survivor-and treatment-related predictors of these impairments, and 3) describe education and employment outcomes and their relation with psychological impairment in these survivors.
MATERIALS AND METHODS

Study Population
The CCSS is a retrospective, multi-institutional cohort study with a detailed methodology and design previously described. 16, 17 Survivors were diagnosed with neuroblastoma before the age of 21 years, were treated at 1 of 27 participating institutions in the United States and Canada between January 1, 1970, and December 31, 1999, and were more than 5 years from their diagnosis at recruitment. The CCSS was approved by the institutional review board at each institution. For this analysis, participants consisted of 859 5-year survivors of neuroblastoma who were younger than 18 years at the completion of the baseline survey and a comparison population of 872 siblings of cancer survivors from the CCSS. Consent was provided by a parent/guardian, who completed a baseline questionnaire that included self-reported demographic information, medical outcomes, and psychosocial outcomes. The study population is detailed in a Consolidated Standards of Reporting Trials diagram (Fig. 1) . A subset of the survivors in this study (n 5 293) diagnosed in 1970-1986 completed a follow-up CCSS survey approximately 15 years after the baseline survey, and it included information regarding adult educational attainment and employment status among other life and health updates. 16, 18 All surveys are available on the CCSS Web site (https://ccss. stjude.org/). 19 
Outcome Measures
The primary outcome for this study was the parentreported Behavior Problem Index (BPI), a 32-item standardized questionnaire included in the CCSS baseline questionnaire that was originally developed for the National Health Survey to describe cognitive, behavioral, and emotional functioning. 20 For each item, parents were asked about their child's behavior on a Likert scale ranging from 1 (not true) to 3 (often true). This instrument examines 5 domains-depression/anxiety, headstrong behavior, attention deficit, peer conflict/social withdrawal, and antisocial behavior-and has been previously validated in adolescent childhood cancer survivors. 21 Scores for each domain were calculated as the mean of the weighted response to questions in that domain. Higher scores indicate worse behavioral symptoms. These raw scores were then converted into z scores with age-and sex-matched means and standard deviations from the sibling control group. In agreement with a past study, 21 impairment was defined as scores elevated beyond the highest 10th percentile of age-matched sibling controls.
Secondary outcomes included the use of special education services; this information was collected for all survivors from the parent report on the baseline questionnaire. Longitudinal assessments of the highest level of educational attainment (some college or higher vs less than college) and unemployment were collected for the subset of survivors (n 5 293) who completed a follow-up survey, as described earlier. 18 We defined unemployment as "unable to work due to illness or disability" or "unemployed but seeking work" in the last 12 months. We did not include voluntary unemployment (ie, student, retirement, maternity leave, or military service) as unemployment for this analysis. We further restricted the educational attainment and unemployment analysis to survivors who were 25 years old at the time of the follow-up survey completion. The follow-up survey assessed self-reported outcomes. 
Independent Variables
Demographic information was collected for both survivors and siblings from the baseline questionnaire. 22 For survivors, cancer-related information (including the date of diagnosis, chemotherapy exposures, radiation exposures, and surgeries) was collected via medical record abstraction. 17 For chemotherapy exposures, we analyzed vincristine, platinum agents, alkylating agents, and/or anthracyclines (yes/no and by the cumulative dose over the 5 years since the diagnosis). For radiation exposures, we examined whether survivors received primary or stray radiation to the brain, chest/neck, abdominal region, or total body (yes/no and by the cumulative dose over the 5 years from the diagnosis). We also considered whether survivors developed certain chronic health conditions: any cardiac disease, any endocrine disease, any pulmonary disease, any renal disease, peripheral neuropathy, hearing loss, and overweight/obese body mass index (85th percentile for age-and sex-specific distributions for US children). 23, 24 These conditions were ascertained by parent report on the baseline questionnaire and were graded with the National Cancer Institute's Common Terminology Criteria for Adverse Events (version 4.03): none (grade 0); mild or asymptomatic (grade 1); moderate (eg, minimal local or noninvasive intervention indicated; grade 2); severe, medically significant, or disabling (grade 3); or life-threatening (grade 4). [25] [26] [27] Peripheral neuropathy was defined as any of the following in the absence of a history of stroke or paralysis: weakness in the arm, weakness in the leg, and sensory neuropathy. In addition, we evaluated activity limitations, 1 of the 6 domains of health status as defined in previous CCSS analyses. 28, 29 Activity limitations were considered present among participants who reported problems with executing moderate activities (eg, walking 1 block, carrying groceries, or climbing a few flights of stairs) for 3 months or more in the past 2 years.
Statistical Analysis
Neuroblastoma survivors with BPI outcomes were compared with those with incomplete/missing BPI data via chi-square tests in terms of age at diagnosis, sex, race, radiation, alkylating agents, and platinum agents. Descriptive statistics for demographic and treatment characteristics of neuroblastoma survivors and CCSS siblings were compared with the chi-square test statistic, with bootstrapping families accounting for potential within-family correlations between survivors and siblings from the same families. The proportions of individuals with scores in the impaired range were described and compared between survivors and siblings for each domain of the BPI. Linear and logistic regression models, adjusted for sex and age at evaluation, were used for the survivor-sibling comparisons of continuous scores and binary impairment outcomes, respectively, with modifications by generalized estimating equations accounting for potential within-family correlations. 30 We also compared these outcomes within our sample of neuroblastoma survivors, using the same models without generalized estimating equations, by treatment modality (surgery only, surgery and chemotherapy, surgery, chemotherapy, and radiation, or other) and by decade of diagnosis (1970-1970, 1980-1989, or 1990-1999) .
Within the survivor cohort, we performed multivariate analyses examining impairment in each of the BPI domains with 3 separate log-binomial models because of the collinearity between treatment exposures and certain chronic health conditions. In the first model, we restricted analyses to sociodemographic factors: age at diagnosis (<1 vs 1 year), sex, race (white vs other), and annual household income (<$20,000, $20,000-$39,999, $40,000-$59,999, or $60,000). In the second model, we restricted analyses to treatment factors (yes/no): retinoic acid, anthracycline, vincristine, any platinum agent, any alkylating agent, cranial radiation, chest/neck radiation, abdominal radiation, and total body irradiation. We additionally examined the interaction of exposures to vincristine and any platinum agent. In the third model, we restricted analyses to chronic health conditions and health status: any cardiac disease (grade 2 or higher), any pulmonary disease (grade 2 or higher), any renal disease (grade 2 or higher), any endocrine disease (grade 2 or higher), hearing loss (grade 3 or 4); peripheral neuropathy (any grade; sensory or motor), body mass index (overweight/obese), and moderate to severe activity limitation (yes/no). These chronic health conditions and health status outcomes were selected a priori because of literature suggesting potential effects on psychological functioning in neuroblastoma survivors, survivors of other childhood cancers, and other populations. 15, [31] [32] [33] [34] [35] [36] [37] [38] In each model, backward selection was used to retain variables with P values < .05 in the final model. Prevalence ratios (PRs) were calculated for each of these sociodemographic characteristics, treatment exposures, and chronic health conditions with P values < .05. All models were adjusted for age at evaluation, sex, and annual household income.
We also examined the overall effect of chronic health conditions (a condition of any grade, at least 1 grade 3 or 4 condition, and 2 or more chronic health conditions of any grade), radiation by quartile, and chemotherapy by Cancer dosing stratification on each BPI domain with a logbinomial model.
Using log-binomial models, we then assessed the relation of impairment in each of the BPI domains with the use of special education services among the survivors. In a subset of survivors for whom we collected educational attainment and unemployment data in the last 12 months (as detailed previously), their associations with impairment in each of the BPI domains were examined.
All analyses were conducted with SAS 9.4 (SAS Institute, Inc, Cary, North Carolina).
RESULTS
Study Population Characteristics
A total of 859 5-year survivors of neuroblastoma were included in this analysis (Fig. 1) . Participants and nonparticipants were similar in terms of sex and race. Participants were younger at diagnosis and were less likely to have received radiation, alkylating agents, or platinum agents (all P values < .01). Table 1 displays baseline demographic and treatment characteristics of the survivors and the sibling comparison group. Siblings did not differ from survivors in terms of sex or race but were slightly older at the baseline evaluation (P 5 .04).
Impairment in the BPI and Associated Factors Among Survivors
Compared with siblings, survivors had a greater proportion impaired in every domain of the BPI (Fig. 2) , including anxiety/depression (P 5 .003), attention deficit (P < .001), peer conflict/social withdrawal (P < .001), headstrong behavior (P < .001), and antisocial behavior (P 5 .01).
Demographic factors
Lower household income was associated with impairment in headstrong behavior (adjusted PR, 1.72; 95% Abbreviations: IQR, interquartile range; N/A, not applicable. a Sixty-nine subjects did not consent to the release of medical records for treatment exposures and were not included. b Exposure to an alkylating agent (ie, cyclophosphamide, ifosfamide, procarbazine, chlorambucil, carmustine, lomustine, melphalan, thiotepa, nitrogen mustard, or busulfan) was determined with the cyclophosphamide equivalent dose according to a methodology previously published. 49 confidence interval [95% CI], 1.12-2.72), attention deficit (PR, 2.12; 95% CI, 1.37-3.44), and peer conflict/social withdrawal (PR, 1.44; 95%, CI, 1.02-2.07) when we compared annual incomes of $20,000 to $39,999 and annual incomes greater than or equal to $60,000 (Table 2) .
Treatment factors
Survivors treated with anthracyclines had more impairment in the antisocial domain (PR, 1.58; 95% CI, 1.07-2.30; Table 2 ) than survivors without such treatment. Cranial radiation (PR, 2.03; 95% CI, 1.32-2.37) predicted impairment in the headstrong domain, whereas abdominal radiation (PR, 1.58; 95% CI, 1.01-2.36) was associated with an increased risk of impairment in the antisocial domain. No other differences associated with treatment exposures were identified (Supporting Table  1 ). There were also no statistical differences in BPI outcomes in survivors when they were compared by treatment group (surgery only, surgery and chemotherapy, surgery, chemotherapy, and radiation, or other; Supporting (Table 4) . Impairment in each of the BPI domains was associated with a 66% to 126% increase in the use of special education services (P < .001) as well as an 89% to 173% increased risk of attainment of less than college education (P .04; Table 4 ). Specifically, impairment in attention deficit was associated with more than a 2-fold increase in the use of special education services (PR, 2.26; 95% CI, 1.86-2.74).
DISCUSSION
This retrospective cohort of 859 pediatric/adolescent survivors of neuroblastoma had a higher prevalence of poor psychological outcomes in comparison with siblings on standardized parent reports. Survivors had higher rates of impairment in anxiety/depression, headstrong behavior, attention deficit, peer conflict/withdrawal, and antisocial domains. We found lower household income to be associated with a greater risk of impairment in 3 of the 5 domains measured. Although there was no clear pattern of association between psychological impairment and treatment intensity or specific treatment risk factors, our results suggest that these impairments may be driven by the burden of chronic health conditions. Having 2 or more chronic health conditions was associated with impairment in multiple psychological domains. Psychological impairment was associated with the use of special education services during childhood/adolescence and longitudinally with lower educational attainment; this indicates that there are potentially downstream concerns that affect adult day-to-day functioning. Our analysis builds on previous studies, which have suggested that neurocognitive functioning and psychosocial well-being are affected in survivors of neuroblastoma. 4, 21, 34, 35 Consistent with previous work in survivors of different cancers, we found lower household income to be associated with worse outcomes. [40] [41] [42] The potential effect of a lower socioeconomic status on worse psychological functioning adds to similar publications concerning children with leukemia. 43, 44 With more data demonstrating the effects of health disparities on both survival and overall functioning after treatment, future studies must focus on addressing these gaps because of the The following were also examined but were N/S: retinoic acid, vincristine, chest/neck radiation, alkylating agents, platinum agents, interaction of age at diagnosis with sex, and interaction of age at diagnosis with each of the treatment factors.
c
The following were also examined but were N/S: grade 2 cardiac disease, grade 2 renal disease, hearing loss, body mass index, physical fitness-limiting daily activities exceeding 3 months, interaction of age at diagnosis with sex, and interaction of age at diagnosis with each of the chronic conditions.
Cancer economic burden of cancer care and the prevalence of financial hardship in this patient population. 45, 46 Interestingly, there was no clear pattern for specific treatment-related risk factors or dose effects for psychological impairment. It is possible that our instrument was not sensitive to some aspects of psychological functioning that may require more comprehensive testing to detect. Also surprisingly, total body irradiation was associated with better, not worse, functioning in peer conflict/social withdrawal. We could find no explanation in our analyses, but we speculate that this association may have been confounded by other factors that we could not measure, such as psychosocial or other supportive-care interventions. The lack of an association between treatment intensity and worse psychological outcomes in our sample offers the possibility that these outcomes may be a general effect of the cancer/survivorship experience. Stein et al 47 proposed a model in which the long-term psychological response to the cancer experience is broken down into the stress and burden of the experience balanced with the resources available to each individual. They detailed the multifaceted components of the burden of the cancer experience, including physical (eg, late effects such as fatigue, weight gain, and infertility) and psychological aspects (eg, fear of recurrence and baseline cognitive function), both of which likely play a role in our neuroblastoma survivor cohort. Specifically, the BPI impairments that we observed in this population may be driven by the overall burden of chronic health conditions. We found that having 2 or more chronic health conditions significantly predicted impairment in 4 of the 5 domains. There is also some evidence suggesting that survivors specifically with pulmonary disease, peripheral neuropathy, and endocrine disease may be at particularly increased risk for psychological impairment because of the >50% increased risk of impairment in these subgroups in at least 3 domains. However, this finding needs to be confirmed in studies with the capacity for a more comprehensive clinical assessment for these conditions, and future work may need to incorporate a more nuanced analysis of these associations.
Compared with siblings, neuroblastoma survivors in our study were more likely to use special education services and have worse outcomes in terms of eventual educational attainment. These long-term outcomes contribute to a body of literature demonstrating that these patients are at increased risk for academic learning problems, which may contribute to a lower quality of life and social development concerns. 34, 48, 49 Impairment in multiple BPI domains was associated with childhood use of special education services, educational attainment less than college, and unemployment as adults. These data suggest that future studies should explore early psychological screening, educational interventions, and supportive services to help maximize success later in life for subsets of this patient population.
To our knowledge, this is the largest analysis focusing on psychological outcomes in neuroblastoma survivors. The CCSS benefits from having a sizeable, multiinstitutional patient cohort with detailed medical recordabstracted treatment information as well as longitudinal follow-up spanning several decades. 16 This study was additionally strengthened by a standardized ascertainment of these outcomes with a validated instrument. 20, 21 These results, however, must be interpreted in light of its limitations. The primary outcomes were based on a parentreport instrument. There are no specific data on agreement between parent-proxy reporting and child selfreporting for the BPI. A systematic review by Upton et al 39 of parent-child agreement across child healthrelated quality of life instruments found that parents of children with health conditions tended to underestimate their quality of life. However, they cautioned that the data remain limited and that the characteristics of parents and children are not consistently considered in these studies. Moreover, the authors acknowledge that parental perception may add different but valuable information that enriches the understanding of a child's functioning. Other authors have similarly concluded that parent-proxy reports remain fundamentally important in pediatric clinical research. 50, 51 It is also important to note that our study cohort ends with survivors diagnosed in 1999. Since that time, there have been changes in the standard-of-care protocol, including the adoption of immunotherapy and cytokines plus isotretinoin for high-risk neuroblastoma. 52 Although our analysis includes retinoic acid, it does not capture the effects of immunotherapy and thus may be more limited in its generalizability.
Results from this study demonstrate that survivors of neuroblastoma are at risk for worse psychological functioning and educational outcomes. Lower household income and having multiple chronic health conditions are notable risk factors. Future studies will benefit from even larger patient samples as overall survival continues to improve. This work should integrate a more comprehensive assessment of neurocognitive and mental health function to better characterize specific deficits in this patient population and evaluate approaches for early screening and intervention to identify individuals at higher risk for worse educational and employment outcomes in adulthood. 
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